Whole Exome Sequencing Market Growth Opportunities: Insights from 2025–2029

Global Whole Exome Sequencing Market

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The Whole Exome Sequencing Industry Compare Between 2025 And 2029?

The whole exome sequencing market has experienced significant expansion in recent years. This market is projected to grow from $2.82 billion in 2024 to $3.36 billion in 2025, at a compound annual growth rate (CAGR) of 19.1%. Its historical growth can be attributed to genomic research advancements, precision medicine trends, rare disease diagnosis, pharmaceutical and biotech applications, and declining sequencing costs.

The whole exome sequencing market is projected to experience substantial growth in the upcoming years. It is predicted to expand to $7.27 billion by 2029, achieving a compound annual growth rate (CAGR) of 21.3%. This anticipated growth during the forecast period stems from factors such as broadening applications in oncology, its increasing integration into clinical diagnostics, a rise in demand for genetic testing, various population genomics initiatives, and the emergence of gene therapies. Noteworthy trends during this period include enhanced clinical utility and wider adoption, a continuous decrease in sequencing costs, a heightened focus on data security and privacy, greater integration with electronic health records, and ongoing advancements in single-cell sequencing.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10669&type=smp

Which Drivers Are Impacting The Whole Exome Sequencing Market?

The rising prevalence of HIV (human immunodeficiency virus) is anticipated to fuel the expansion of the whole exome sequencing market in the coming years. HIV is defined as a virus that attacks the body’s immune system. Whole exome sequencing provides the genomic structures of viruses, which are valuable for developing personalized treatments and vaccine designs specifically for HIV. For example, in August 2024, the Minority HIV/AIDS Fund (MHAF), a US-based government agency, reported that an estimated 39.9 million individuals worldwide were living with HIV in 2023, including 38.6 million adults and 1.4 million children, a higher number compared to previous years. Consequently, the growing incidence of HIV is boosting the growth of the whole exome sequencing market.

How Is The Whole Exome Sequencing Market Classified Into Different Segments?

The whole exome sequencingmarket covered in this report is segmented –

1) By Product: Systems; Kits; Services

2) By Technology: Sequencing By Synthesis; Ion Semiconductor Sequencing; Other Technologies

3) By Application: Diagnostics; Drug Discovery And Development; Personalized Medicine; Agriculture And Animal Research

4) By End-User: Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Academic and Research Institutes; Clinical Laboratories; Other End-Users

Subsegments:

1) By Systems: Sequencing Systems; Data Analysis Systems

2) By Kits: Library Preparation Kits; Exome Enrichment Kits; Sequencing Kits

3) By Services: Data Analysis Services; Consulting Services; Custom Sequencing Services

What Trends Are Expected To Drive The Whole Exome Sequencing Market?

The whole exome sequencing market is witnessing a growing popularity in innovative diagnostic techniques. To sustain their market position, companies active in the whole exome sequencing market are focusing on developing new product innovations. For instance, in February 2023, Illumina Inc., a US-based biotechnology company, unveiled NovaSeqX Plus, representing the most powerful sequencing technology available. This system offers an unparalleled combination of high throughput and accuracy, along with streamlined informatics, advancements in sustainability, and economical sequencing. The innovations integrated into the NovaSeq X Plus systems are capable of generating tens of thousands of whole genomes per year, maximizing productivity, and minimizing turnaround time.

Which Leading Players Are Enhancing Their Whole Exome Sequencing Market Presence Worldwide?

Major companies operating in the whole exome sequencing market include Thermo Fisher Scientific Inc., Illumina Inc., Eurofins Genomics, Azenta US Inc., CD Genomics, Psomagen Inc., Agilent Technologies, BGI Genomics, F. Hoffmann-La Roche Ltd., QIAGEN Inc., Macrogen Inc., Ambry Genetics, Bio-Rad Laboratories Inc., Bioneer Corporation, Foundation Medicine Inc., KONICA MINOLTA INC., Otogenetics Corporation, Geneyx Genomex Ltd., ArcherDX Inc., Blueprint Genetics Oy, Bionano Genomics Inc., Centogene AG, Fulgent Genetics Inc., Natera Inc., GeneDx Inc., GENEWIZ Inc., Novogene Corporation, PerkinElmer Inc., Personalis Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/whole-exome-sequencing-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Whole Exome Sequencing Market?

North America was the largest region in the whole exome sequencing market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global whole exome sequencing market report during the forecast period. The regions covered in the whole exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Whole Exome Sequencing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=10669&type=smp

Browse Through More Reports Similar to the Global Whole Exome Sequencing Market 2025, By The Business Research Company

Rna Analysis Transcriptomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report

Antisense And Rnai Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antisense-and-rnai-therapeutics-global-market-report

Next Generation Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model